Bill

Bill > A5359


NJ A5359

NJ A5359
Classifies 7 Hydroxymitragynine as Schedule I drug.


summary

Introduced
09/10/2026
In Committee
09/10/2026
Crossed Over
Passed
Dead

Introduced Session

2026-2027 Regular Session

Bill Summary

This bill would classify 7 hydroxymitrgynine (7-OH) as a Schedule I controlled dangerous substance. 7-OH is one of the psychoactive alkaloids naturally found in the Mitragyna speciosa plant, commonly known as Kratom. 7-OH, in higher concentrations when metabolized by the body, can produce opioid-like effects and can have similarly addictive qualities. Kratom, which contains 7-OH in lower concentrations in its natural form, is frequently marketed for its psychoactive and opioid-like analgesic effects and for use in the treatment of certain opioid addictions and withdrawal symptoms, a treatment which has not been conclusively proven. The federal Food and Drug Administration (FDA) has advised that 7-OH poses a threat to public health and has the potential for abuse because of its ability to blind opioid receptors in the brain. The FDA has issued a number of warnings and conducted seizures of illegally sold, unapproved, or misbranded drug products containing potentially lethal doses of synthetic 7-OH, which contain higher concentrations of the psychoactive alkaloid. Currently, Kratom and 7-OH have not been approved by the FDA for any medical use. Further, on July 29, 2025, the FDA also recommended that 7-OH be scheduled under the federal "Controlled Substances Act," 21 U.S.C.s.812. Until the drug is scheduled under the federal act, 7-OH is not presently barred by federal law. It is also not presently barred by New Jersey law. Under this bill, 7-OH would be classified as a Schedule I drug in this State. 7-OH would be placed on the Schedule I list of the "New Jersey Controlled Dangerous Substances Act," P.L.1970, c.226 (C.24:21-1 et seq.), which would define the drug as a substance that: (1) has high potential for abuse; and (2) has no accepted medical use in treatment in the United States; or lacks accepted safety for use in treatment under medical supervision. By classifying 7-OH as a Schedule I drug, under the "Comprehensive Drug Reform Act of 1987," N.J.S.2C:35-1 et seq., the drug would be considered illegal controlled dangerous substances for which manufacturing, distribution, or possession with intent to manufacture or distribute would be punishable as either: a crime of the second degree, if the act involved a quantity of one ounce or more; or a crime of the third degree, if the act involved less than one ounce.

AI Summary

This bill classifies 7 Hydroxymitragynine (commonly known as 7-OH, a psychoactive compound found in the kratom plant that can produce opioid-like effects and carries a high potential for abuse) as a Schedule I controlled dangerous substance under New Jersey law. By adding this substance to the state's Schedule I list—which is reserved for drugs with a high potential for abuse and no accepted medical use—the legislation makes the manufacturing, distribution, or possession with intent to distribute 7-OH illegal, subjecting offenders to criminal penalties that range from a third-degree to a second-degree crime depending on the quantity involved.

Committee Categories

Justice

Sponsors (3)

Last Action

Introduced, Referred to Assembly Judiciary Committee (on 09/10/2026)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
  • ‐ Illegal Drugs and Narcotics Control

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location Created
State Bill Page https://www.njleg.state.nj.us/bill-search/2026/A5359 06/30/2026
BillText https://pub.njleg.gov/Bills/2026/A5500/5359_I1.HTM 09/11/2026
Loading...